Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Bacterial vaginosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    22 result(s) found for: Bacterial vaginosis. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2011-002386-38 Sponsor Protocol Number: CLVS100VER Start Date*: 2011-09-30
    Sponsor Name:VERISFIELD (UK) LTD
    Full Title:
    Medical condition: Bacterial Vaginosis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10004055 Bacterial vaginosis LLT
    Population Age: Adults Gender: Female
    Trial protocol: GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-011826-32 Sponsor Protocol Number: RFX-VAG/002/2008 Start Date*: Information not available in EudraCT
    Sponsor Name:Alfa Wassermann S.p.A.
    Full Title: A phase II, multicentre, double-blind, randomised, placebo-controlled study on efficacy and tolerability of Rifaximin vaginal tablets in the treatment of bacterial vaginosis
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004055 Bacterial vaginosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-007874-39 Sponsor Protocol Number: PGX401-08 Start Date*: 2009-03-19
    Sponsor Name:Innotech international
    Full Title: Etude multicentrique en ouvert sur l'efficacité et la tolérance d'un traitement local avec polygynax au cours des vaginites mycosiques et/ou bactériennes
    Medical condition: Vaginites Mycosiques et/ou bactériennes
    Disease: Version SOC Term Classification Code Term Level
    9.1 10062167 Vaginitis bacterial LLT
    9.1 10046956 Vaginitis bacterial NOS LLT
    9.1 10001107 Acute vaginitis LLT
    9.1 10048238 Yeast vaginitis LLT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2020-002489-15 Sponsor Protocol Number: 380119 Start Date*: 2021-03-23
    Sponsor Name:Medinova AG
    Full Title: Comparative study of the efficacy and safety of vaginally applied Dequalinium Chloride (10 mg) and orally applied Metronidazole (2 x 500 mg) in the treatment of bacterial vaginosis
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Prematurely Ended) SK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-004563-37 Sponsor Protocol Number: IPR_GARDEFLORA_15-2 Start Date*: 2016-12-27
    Sponsor Name:Laboratoires IPRAD PHARMA
    Full Title: Study of the efficacy and safety of treatment with completely lyophilised cultures of Lactobacillus crispatus - IP 174178 administered intravaginally in the treatment of bacterial vaginosis.
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10046960 Vaginosis bacterial LLT
    Population Age: Adults Gender: Female
    Trial protocol: PL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-003356-51 Sponsor Protocol Number: ZEL001 Start Date*: 2015-10-15
    Sponsor Name:Zelmic AB
    Full Title: A single-centre, open-label, single-arm, Phase I/II study to investigate the effect of a hydrogen peroxide foam on clinical signs and symptoms and the vaginal flora in patients with bacterial vagin...
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    18.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-000694-39 Sponsor Protocol Number: SPL7013-018 Start Date*: 2014-10-22
    Sponsor Name:Starpharma Pty Ltd
    Full Title: A phase 3, double-blind, multicentre, randomised, placebo-controlled study to determine the efficacy and safety of SPL7013 Gel (VivaGel®) to prevent the recurrence of bacterial vaginosis
    Medical condition: recurrent bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) GB (Completed) HU (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2006-004398-89 Sponsor Protocol Number: 380104 Start Date*: 2006-12-06
    Sponsor Name:Medinova AG
    Full Title: Comparative Study of the Efficacy of 10 mg Dequalinium Chloride (Fluomizin®) in the Local Treatment of Bacterial Vaginosis
    Medical condition: Bacterial Vaginosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10004055 Bacterial vaginosis LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) AT (Prematurely Ended) CZ (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2016-004483-19 Sponsor Protocol Number: RRK5908 Start Date*: 2017-09-09
    Sponsor Name:University Hospitals Birmingham NHS Foundation Trust
    Full Title: A randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
    Medical condition: Bacterial Vaginosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2021-004579-16 Sponsor Protocol Number: FU-04-21 Start Date*: 2022-01-18
    Sponsor Name:Adamed Pharma S.A.
    Full Title: A Phase II, Randomized, Parallel design, Open label, Dose ranging Study to evaluate the efficacy and safety of Furazidin vaginal tablets in women with bacterial vaginosis
    Medical condition: Bacterial Vaginosis (BV)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adults Gender: Female
    Trial protocol: PL (Completed) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-004292-41 Sponsor Protocol Number: BECRO/VF/FEMALE Start Date*: 2017-02-20
    Sponsor Name:Verisfield (UK) Ltd., Greek branch
    Full Title: Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a Generic Formulation of Vaginal Ovule conta...
    Medical condition: Bacterial Vaginosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046960 Vaginosis bacterial LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GR (Completed)
    Trial results: View results
    EudraCT Number: 2014-001759-22 Sponsor Protocol Number: PGX401-11 Start Date*: 2015-07-24
    Sponsor Name:Laboratoire Innotech International
    Full Title: Assessment of the efficacy of POLYGYNAX® in the empirical treatment of infectious vaginitis International, multicentre, randomised, double-blind, parallel group study, comparative versus miconazole
    Medical condition: Patients presenting with abnormal vaginal discharge associated with other vaginal symptoms (i.e. vaginal burning and/or vaginal irritation and/or vaginal pain) clinically evoking infectious vaginit...
    Disease: Version SOC Term Classification Code Term Level
    18.0 10021881 - Infections and infestations 10046950 Vaginitis LLT
    18.0 10021881 - Infections and infestations 10046914 Vaginal infection PT
    18.0 10021881 - Infections and infestations 10001107 Acute vaginitis LLT
    18.0 10021881 - Infections and infestations 10029562 Non-specific vaginitis LLT
    18.0 10021881 - Infections and infestations 10062167 Vaginitis bacterial PT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed) CZ (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2009-017901-12 Sponsor Protocol Number: LYO_2009-09 Start Date*: 2010-02-26
    Sponsor Name:LYOCENTRE
    Full Title: Etude de l’efficacité et de la tolérance du traitement par la culture totale lyophilisée de lactobacillus casei variété rhamnosus (Lcr35 Lc) administré par voie vaginale dans la prévention de réci...
    Medical condition: vaginose bactérienne récidivante
    Disease: Version SOC Term Classification Code Term Level
    12.1 10004055 Bacterial vaginosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-007659-15 Sponsor Protocol Number: NC-07-03 Start Date*: 2008-04-22
    Sponsor Name:Lumavita AG
    Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Investigate the Efficacy, Safety, and Tolerability of 3 doses of SPK 0602 (pentamycin) Vaginal Tablets vs Placebo (veh...
    Medical condition: Symptomatic Vaginitis due to Bacterial Vaginosis, Candidiasis or Trichomoniasis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10062167 Vaginitis bacterial PT
    9.1 10046950 Vaginitis LLT
    9.1 10046958 Vaginitis trichomonal LLT
    9.1 10048238 Yeast vaginitis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: EE (Completed) DE (Completed) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002918-12 Sponsor Protocol Number: 1-2013-HU Start Date*: Information not available in EudraCT
    Sponsor Name:Amvac Kft
    Full Title: Randomized, prospective, double blind clinical study to evaluate the effectiveness, dosage and safety of lactobacillus vaccine for management of bacterial vaginosis in a non-selected patient popula...
    Medical condition: Bacterial vaginosis (Nugent score 4 or above)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: HU (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-004890-10 Sponsor Protocol Number: KI DS 200509 Start Date*: 2006-02-17
    Sponsor Name:Kvinnokliniken
    Full Title: Vaginal colonization of the LN bacteria (patented human lactic acid producing bacteria) when conventional treatment of bacterial vaginosis and Candida vaginitis is followed by treatment with Vagipi...
    Medical condition: Diagnosed Bacterial Vaginosis (BV) or Candida Vaginitis(CV) ICD: N76.8 (BV); N77.1*B37.3+(CV)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000752-33 Sponsor Protocol Number: SPL7013-016 Start Date*: 2012-06-22
    Sponsor Name:Starpharma Pty Ltd
    Full Title: A phase 3, double-blind, multicenter, randomized, placebo-controlled study to assess the efficacy and safety of SPL7013 Gel (VivaGel®) for the treatment of bacterial vaginosis
    Medical condition: Bacterial vaginosis
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2019-002819-25 Sponsor Protocol Number: GU18/108645 Start Date*: 2020-04-22
    Sponsor Name:Leeds Teaching Hospital NHS Trust
    Full Title: Dequalinium versus usual care antibiotics for the treatment of bacterial vaginosis (DEVA): a multicentre, randomised, open label, non-inferiority trial
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2018-002376-41 Sponsor Protocol Number: MICINT Start Date*: 2018-09-10
    Sponsor Name:Zealand University Hospital, Gynecological department
    Full Title: Modulating the Vaginal Microbiome after Implantation Failure - A randomized placebo controlled study of lactobacilli supplements
    Medical condition: Sub-optimal vaginal and/or endometrial microbiome.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046960 Vaginosis bacterial LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2011-003147-22 Sponsor Protocol Number: GLBR-101-2011 Start Date*: 2011-12-02
    Sponsor Name:Glenmark Farmaceutica LTDA
    Full Title: A Multicenter, Open-Label, Comparator-Controlled, Parallel Group, Phase 3 Study to Assess the Efficacy and Safety of Clotrimazole/Clindamycin (200 mg/100 mg FDC) Ovules Compared with Metronidazole ...
    Medical condition: vaginitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10046950 Vaginitis LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 20:05:22 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA